accountn"(Reuters) - Pfizer Inc (PFE.N Last month, The drug dimebon failed to show efficacy in a late-stage trial for Alzheimer's. However, Medivation said it will continue to test the drug in...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer, Medivation say Huntington drug fails study
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account